Loading...
Belimumab in Systemic Lupus Erythematosus
Belimumab is the only approved biological agent for the treatment of systemic lupus erythematosus (SLE). It is a fully humanized IgG1γ monoclonal antibody directed against soluble B lymphocyte stimulator (BLyS). It is indicated as an add-on therapy for the treatment of adult patients with active, au...
Na minha lista:
| Udgivet i: | Indian J Dermatol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5029243/ https://ncbi.nlm.nih.gov/pubmed/27688447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.190107 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|